CenterWatch News Online | News and views on the clinical trials industry

Miscellaneous

1 2 3 4 5 6 7 8 9 10 Next 10

Criterium Registers in Canada, Creates New Positions

Tuesday, May 13, 2008 05:25 AM

Saratoga, N.Y.-based contract research organization (CRO) Criterium is planning to open an office in Toronto. The move was client-driven and will be where the company’s newly appointed director of global affairs, Lawrence Reiter, Ph.D., is based.

More... »

Project Delays Hurt etrials in First Quarter

Monday, May 12, 2008 11:32 AM

Morrisville, N.C.-based eClinical company etrials reported another challenging quarter with a drop in net service revenue of $3.7 million for the first quarter of 2008 compared to $4.1 million reported in 2007. Quarter over quarter, the company’s profit losses widen with a $2.0 million net loss for the quarter (or $0.19 per share) compared with a loss of $900,000 during the first quarter of 2007. etrials stated that its drop in revenue was partly due to new project delays, resulting in about $1 million in lost revenue.

More... »

CWWeekly May 5th 2008 Issue

Friday, May 9, 2008 10:18 AM

Top News

More... »

Gene Therapy Shows Promise for Rare Childhood Blindness

Tuesday, May 6, 2008 04:45 PM

Targeted Genetics reported positive results from a phase I/II trial of its RPE65 gene therapy for the treatment of retinal dystrophy due to Leber’s congenital amaurosis (LCA). LCA is a rare eye disease that causes severe vision loss or blindness. The disease is genetically inherited and usually manifests itself at birth or in early infancy. There are thought to be 3,000 people in the U.S. with the disease; however, the technology has the potential to treat a variety of eye diseases such as macular degeneration which afflicts 1.25 million people in the U.S. alone.

More... »

PharmaNet Sees Profits Sink in Q1 due to Cancellations

Monday, May 5, 2008 02:14 PM

Princeton, N.J.-based contract research organization (CRO) PharmaNet Development Group dropped out of the black with a reported net loss of $10.1 million for the first quarter of 2008, primarily due to canceled contracts. PharmaNet cut its guidance for 2008 and its stock plunged 28% on May 1 to $17.10, far off its 52-week high of $43.05.

More... »

CWWeekly April 28th 2008 Issue

Friday, May 2, 2008 03:44 PM

Top News

More... »

Veeda Expands Global Capacity with New Oncology CRO

Thursday, May 1, 2008 04:50 PM

Ahmedabad-based CRO Veeda Clinical Research, launched a new division, called Global Oncology CRO, to concentrate on cancer research while leveraging Veeda’s operational capacities in the United States, Europe and India. The oncology subsidiary will be led by its president and chief executive officer, Matt Bowman. The new business will be headquartered in Columbus, Ohio. Kathy Squillace was named to the position of vice president of clinical operations and Dave Colborn was made vice president of data management and information technology.

More... »

New England Research Institutes Partners With Evidence

Monday, April 28, 2008 10:45 AM

Watertown, Mass.-based CRO New England Research Institutes (NERI) established a strategic partnership with Evidence Clinical and Pharmaceutical Research Institute, a CRO which focuses on conducting trials in Russia and Eastern Europe. Evidence is headquartered in Saint-Petersburg, Russia, and has offices in Los Altos, Calif., and Swampscott, Mass. The companies stated that both Eastern Europe and Russia are becoming increasingly popular regions for conducting clinical trials, and sponsors are creating an ever larger presence there.

More... »